Vertical HIV-1 transmission: Prophylaxis and paediatric follow-up

Placenta

Volumn 22, Issue , 2001, Pages S13-S18

  Carneiro, M ^a   Sanchez A ^a   Maneiro, P ^a   Angelosante, W ^a   Perez C ^a   Vallee M ^a  

^a Maternidad Concepcion Palacios   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; LAMIVUDINE; RITONAVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; DISEASE TRANSMISSION; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PATHOGENICITY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-HIV AGENTS; DIDANOSINE; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV-1; HUMANS; LAMIVUDINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RITONAVIR; VIRAL LOAD; ZIDOVUDINE;

EID: 0005579143     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2001.0670     Document Type: Article

References (23)

1. Berer M (1999) Reducing perinatal HIV transmission in developing countries through antenatal and delivery care and breast-feeding: Supporting infant survival by supporting women's survival. Bull World Hlth Org, 77, 871-877
2. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, Rotig A, Mayaux MJ & Delfraissy JF (1999) Persistent mitochondrial dysfunction in perinatal exposure to Anyiretroviral nucleosides analogues. Lancet, 354, 1084-1089
3. Brinkman K, ter Hofstede HJM, Burger DM, Smeitink JA & Koopmans PP (1998) Adverse effects of reverse transcriptase inhibitors: Mitochondria toxicity as common pathway. AIDS, 12, 1735-1744
4. Centers for Disease Control (1987) CDC Classification System for HIV in Children. MMWR, 36, 225-230, 235
5. Centers for Disease Control (1994) CDC Classification System Modified. MMWR, 43No RR-12)
6. Centers for Disease Control (1995) Update: AIDS Among Women-United States. MMWR, 44, 81-84
7. Centers for Disease Control and Prevention (1994) Recommendations for the use of Zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR, 43, 1-19
8. Connor EM, Sperling RS, Gelver R, Kiselev P, Scott G, O'Sullivan MJ, Van Dyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy F, Culnane M, Coombs R, Elkins M, Moye J, Stratton P & Balsley J (1994) Reduction of maternal - infant transmission of human immunodeficiency virus type 1 with Zidovudine treatment. Pediatrics AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med, 31, 1173-1180
9. Culnane M, Fowler MG, Lee SS, Mc Sherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flywn PM, Cunningham B & Oleske J (1999) Lack of long-term effects of in utero exposure to Zidovudine among uninfected children born to HIV-infected women. J Am Med Assoc, 281, 151-157
10. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C & Lew JF (1999) Risk factors for perinatal transmission of human immunodeficiency virus type-1 in women treated with Zidovudine. N Eng J Med, 341, 394-402
11. International Perinatal HIV-1 Group (1999) The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. New Engl J Med, 340, 977-987
12. Levine A (1998) HIV Disease in women. HIV clinical management, vol. 9. Medscape
13. Lindegren ML, Byers RH Jr, Thomas P, Davis SF, Caldwell B, Rogers M, Gwinn M, Ward JW & Fleming PL (1999) Trends in perinatal transmission of HIV-1 AIDS in the United States. J Am Med Assoc, 282, 531-538
14. Lindsay MK (1993) The risk of sexually transmitted diseases in human immunodeficiency virus-infected parturients. AmJ Obstet Gynecol, October, 169, 1031-1035
15. Miotti PG, Taha TET, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, Chiphangwi JD, Liomba G & Biggar RJ (1999) HIV transmission through breastfeeding: A study in Malawi. J Am Med Assoc, 282, 744-749
16. Mock PA, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, Roongpisuthipong A, Chinayon P, Kalish ML, Parekh B & Mastro TD (1999) Maternal viral load and timing of mother-to-child HIV-1 transmission. AIDS, 13, 407-414
17. Mofeson LM, Lambert JS, Stiehm ER, Bethel J, Meyer III WA, Whitehouse J, Moyer J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ & Nemo GJ for the Pediatric AIDS Clinical Trials Group Study 185 Team (1999) Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with Zidovudine. N Engl J Med, 341, 385-393
18. Nesheim S, Lee F, Kalish M, Ou CY, Sawyer M, Clark S, Meadows L, Grimes V, Simonds RJ & Nahmias A (1997) Diagnosis of perinatal human immunodeficiency virus infection by polimerase chain reaction and P24 antigen detection after immunocomplex dissociation in an urban community hospital. J Infect Dis, 175, 1333-1336
19. Sperling RS, Shapiro DE, Mc Sherry GD, Britto P, Cunningham BE, Culnane M, Coombs RW, Scott G, Van Dyke RB, Shearer WT, Jimenez E, Diaz C, Harrison DD & Delfraissy JF (1998) Safety of the maternal-infant Zidovudine regimen utilized in the pediatrics AIDS clinical trials group 076 study. AIDS, 12, 1805-1813
20. Shah MM, Li Y & Christensen RD (1996) Effects of perinatal Zidovudine on hematopoiesis: A comparison of effects on progenitors from human fetuses versus mothers. AIDS, 10, 1239-1241
21. Tovo PA, Gabiano C & Tulisso S (1997) Maternal Clinical factors influencing HIV-1 transmission. Acta Paediat Suppl, June, 421, 52-55
22. Watson WJ, Stevens TP & Weinberg GA (1998) Profound anemia in a newborn infant of a mother receiving antiretroviral therapy. Ped Infect Dis J, 17, 435-436
23. World Health Organization (1993) The HIV/AIDS pandemic 1993 overview. Geneva: WHO